Thomas Scoot Johnston
Geen lopende functies
Profiel
Thomas Scoot Johnston worked as a Director of Business Development at Schlumberger GmbH, a Principal at Microsoft Corp., a Vice President of Strategy at Novavax, Inc., and a Manager of Network Administration at Comcast Corp.
He also served as the Chief Business Officer at Mucosis BV from 2011 to 2012.
Johnston received his undergraduate degree from Arcadia University and his MBA from The Wharton School of the University of Pennsylvania.
Eerdere bekende functies van Thomas Scoot Johnston
| Bedrijven | Functie | Einde |
|---|---|---|
Mucosis BV
 Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Algemeen Directeur | - |
| COMCAST CORPORATION | Corporate Officer/Principal | - |
| NOVAVAX, INC. | Corporate Officer/Principal | - |
| SCHLUMBERGER AG | Corporate Officer/Principal | - |
| MICROSOFT CORPORATION | Corporate Officer/Principal | - |
Opleiding van Thomas Scoot Johnston
| Arcadia University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MICROSOFT CORPORATION | Technology Services |
| NOVAVAX, INC. | Health Technology |
| COMCAST CORPORATION | Consumer Services |
| Bedrijven in privébezit | 2 |
|---|---|
Schlumberger GmbH /Austria/
 Schlumberger GmbH /Austria/ Beverages: AlcoholicConsumer Non-Durables Schlumberger AG operates as a holding company, which engages in the production, sale, and distribution of alcoholic and non-alcoholic beverages. The firm offers wine, sparkling wine, champagne, and spirituous beverages. It distributes its products under the Gurktaler Alpenkräuter, Rossbacher, Underberg, Asbach, Bols, Metaxa, Leibwächter, Nonino, Stock, Remy Martin, Stolichnaya, XUXU, evian, Volvic, Badoit, Riemerschmid, and SENS brands. The company was founded by Robert Alwin Schlumberger in 1842 and is headquartered in Vienna, Austria. | Consumer Non-Durables |
Mucosis BV
Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Commercial Services |